Allopurinol in Chronic Heart Failure

The requested reference [d5c5be3249e7f0984eec0c02d86ca23a9a01a8fc] no longer exists in our database. It has been replaced by the current reference: [0e4e24bdeabae6a597410270ad9581198b92bf11]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to discover whether the inhibition of the xanthine oxidase with allopurinol leads to a reduction of the production of oxygen free radicals in patients with CHF and thereby improves characteristics of oxydative metabolism, peripheral blood flow, immune function and functional status.
Epistemonikos ID: 65c3cd94bfb065de24cc8f9f9e881d3c6988fee4
First added on: May 05, 2024